StockData

AGM vs NewGenIvf

AGMH and NIVF side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AGMH and NIVF compare

NewGenIvf grew revenue faster over the last twelve months (336% versus −4.6% for AGM).

NewGenIvf keeps more of each dollar of sales as profit, with a net margin of 41.7% compared with 1.8% at AGM.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAGMHNIVF
Size and price
Share price$0.382$0.173
Change, 1 year−88.1%−100.0%
Change, 5 years−99.9%–
Beta (5Y)3.03–
Employees1187
StockData Score
Total score77
Valuation score00
Growth score02 (better)
Performance score24 (better)
Health score5 (better)1
Dividend score00
Growth
Revenue growth (TTM)−4.6%336% (better)
Revenue growth, 5Y average256%–
Net income growth (TTM)−82.0%–
EPS growth (TTM)−95.0%–
Profitability
Gross margin10.3% (better)4.0%
Operating margin−15.3% (better)−45.2%
Net margin1.8%41.7% (better)
FCF margin−13.3% (better)−46.7%
Return on equity1.8%77.9% (better)
Return on invested capital−7.9% (better)−70.9%
Financial health
Debt / equity0.00–
Interest coverage–−17.4×
Current ratio13.27 (better)1.06
Piotroski F-score45 (better)
Ownership
Held by institutions7.6%–
Insider net buying, 12 months–$4.2M

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.